The inhibition in vitro of hepatic protein biosynthesis by various oral hypoglycemic agents--site of action.
D000818:Animals; D002247:Carbon Isotopes; D002747:Chlorpropamide / Q000494:pharmacology; D005260:Female; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007930:Leucine / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008239:Lysine / Q000378:metabolism; D008861:Microsomes / Q000187:drug effects / Q000378:metabolism; D010629:Phenformin / Q000494:pharmacology; D010649:Phenylalanine / Q000378:metabolism; D014176:Protein Biosynthesis; D012343:RNA, Transfer / Q000378:metabolism; D051381:Rats; D013997:Time Factors; D014044:Tolbutamide / Q000494:pharmacology
D002247:Carbon Isotopes; D007004:Hypoglycemic Agents; D010649:Phenylalanine; D012343:RNA, Transfer; D014044:Tolbutamide; D010629:Phenformin; D007930:Leucine; D008239:Lysine; D002747:Chlorpropamide